SIGA Technologies, Inc. (SIGA)
USD 5.73
(-5.91%)
USD 5.73
(-5.91%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.46 Million USD | 177.19% |
| 2022 | 528.17 Thousand USD | 13.14% |
| 2021 | 466.83 Thousand USD | 3.75% |
| 2020 | 449.94 Thousand USD | -99.44% |
| 2019 | 80.46 Million USD | 6.51% |
| 2018 | 75.54 Million USD | 6.33% |
| 2017 | 71.05 Million USD | 6.76% |
| 2016 | 66.55 Million USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 1.98 Million USD | -49.73% |
| 2013 | 3.95 Million USD | -19.37% |
| 2012 | 4.91 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 130.32 Thousand USD | -39.16% |
| 2005 | 214.22 Thousand USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 11.2 Thousand USD | -94.17% |
| 2001 | 192.19 Thousand USD | -84.5% |
| 2000 | 1.23 Million USD | 55.0% |
| 1999 | 800 Thousand USD | -27.27% |
| 1998 | 1.1 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.3 Million USD | -10.97% |
| 2024 Q2 | 1.62 Million USD | 24.58% |
| 2023 FY | 1.46 Million USD | 177.19% |
| 2023 Q1 | 536.62 Thousand USD | 1.6% |
| 2023 Q2 | 545.55 Thousand USD | 1.66% |
| 2023 Q3 | 554.73 Thousand USD | 1.68% |
| 2023 Q4 | 1.46 Million USD | 163.91% |
| 2022 Q1 | 486.75 Thousand USD | 4.27% |
| 2022 Q2 | 507.14 Thousand USD | 4.19% |
| 2022 Q3 | 519.19 Thousand USD | 2.38% |
| 2022 Q4 | 528.17 Thousand USD | 1.73% |
| 2022 FY | 528.17 Thousand USD | 13.14% |
| 2021 Q4 | 466.83 Thousand USD | -6.01% |
| 2021 FY | 466.83 Thousand USD | 3.75% |
| 2021 Q3 | 496.68 Thousand USD | 14.59% |
| 2021 Q1 | 393.93 Thousand USD | -12.45% |
| 2021 Q2 | 433.43 Thousand USD | 10.03% |
| 2020 Q2 | 434.13 Thousand USD | 1.66% |
| 2020 Q4 | 449.94 Thousand USD | 1.8% |
| 2020 Q3 | 441.99 Thousand USD | 1.81% |
| 2020 FY | 449.94 Thousand USD | -99.44% |
| 2020 Q1 | 427.06 Thousand USD | -99.47% |
| 2019 Q1 | 76.65 Million USD | 1.47% |
| 2019 Q3 | 79.32 Million USD | 1.46% |
| 2019 Q2 | 78.18 Million USD | 1.99% |
| 2019 FY | 80.46 Million USD | 6.51% |
| 2019 Q4 | 80.46 Million USD | 1.44% |
| 2018 Q2 | 73.28 Million USD | 1.55% |
| 2018 Q4 | 75.54 Million USD | 1.52% |
| 2018 Q1 | 72.15 Million USD | 1.56% |
| 2018 FY | 75.54 Million USD | 6.33% |
| 2018 Q3 | 74.41 Million USD | 1.55% |
| 2017 Q3 | 69.91 Million USD | 1.65% |
| 2017 FY | 71.05 Million USD | 6.76% |
| 2017 Q1 | 67.66 Million USD | 1.67% |
| 2017 Q2 | 68.78 Million USD | 1.66% |
| 2017 Q4 | 71.05 Million USD | 1.62% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | 66.55 Million USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | 66.55 Million USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | -100.0% |
| 2015 Q1 | - USD | -100.0% |
| 2014 FY | 1.98 Million USD | -49.73% |
| 2014 Q4 | 1.98 Million USD | -19.89% |
| 2014 Q3 | 2.48 Million USD | -16.56% |
| 2014 Q2 | 2.97 Million USD | -14.17% |
| 2014 Q1 | 3.46 Million USD | -12.38% |
| 2013 Q1 | 4.92 Million USD | 0.26% |
| 2013 FY | 3.95 Million USD | -19.37% |
| 2013 Q4 | 3.95 Million USD | -11.0% |
| 2013 Q3 | 4.44 Million USD | -62.73% |
| 2013 Q2 | 11.93 Million USD | 142.46% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | 4.91 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 4.91 Million USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q2 | 86.76 Thousand USD | -20.07% |
| 2007 Q1 | 108.54 Thousand USD | -16.71% |
| 2006 Q2 | 3.17 Million USD | 167.17% |
| 2006 FY | 130.32 Thousand USD | -39.16% |
| 2006 Q4 | 130.32 Thousand USD | -95.86% |
| 2006 Q3 | 3.15 Million USD | -0.66% |
| 2006 Q1 | 1.18 Million USD | 454.25% |
| 2005 Q4 | 214.22 Thousand USD | -11.15% |
| 2005 FY | 214.22 Thousand USD | 0.0% |
| 2005 Q2 | 267.98 Thousand USD | 0.0% |
| 2005 Q3 | 241.1 Thousand USD | -10.03% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | -100.0% |
| 2002 Q1 | 131.37 Thousand USD | -31.64% |
| 2002 Q4 | 11.2 Thousand USD | -78.7% |
| 2002 Q3 | 52.61 Thousand USD | -43.21% |
| 2002 Q2 | 92.65 Thousand USD | -29.47% |
| 2002 FY | 11.2 Thousand USD | -94.17% |
| 2001 Q2 | 444.69 Thousand USD | -65.82% |
| 2001 Q3 | 286.13 Thousand USD | -35.66% |
| 2001 Q1 | 1.3 Million USD | 4.93% |
| 2001 FY | 192.19 Thousand USD | -84.5% |
| 2001 Q4 | 192.19 Thousand USD | -32.83% |
| 2000 FY | 1.23 Million USD | 55.0% |
| 2000 Q3 | 1.17 Million USD | 4.7% |
| 2000 Q4 | 1.23 Million USD | 5.79% |
| 2000 Q1 | 1.02 Million USD | 27.91% |
| 2000 Q2 | 1.11 Million USD | 9.4% |
| 1999 Q3 | 800 Thousand USD | -11.11% |
| 1999 Q2 | 900 Thousand USD | 0.0% |
| 1999 Q1 | 900 Thousand USD | -18.18% |
| 1999 FY | 800 Thousand USD | -27.27% |
| 1999 Q4 | 800 Thousand USD | 0.0% |
| 1998 FY | 1.1 Million USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | 1.1 Million USD | 0.0% |
| 1998 Q4 | 1.1 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 58.96 Million USD | 97.517% |
| Harrow Health, Inc. | 190.5 Million USD | 99.231% |
| Dynavax Technologies Corporation | 256.91 Million USD | 99.43% |
| Biofrontera Inc. | 5.39 Million USD | 72.884% |
| Cronos Group Inc. | 2.53 Million USD | 42.36% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -140.791% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 99.795% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 95.969% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -24.808% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 92.056% |
| Radius Health, Inc. | 365.31 Million USD | 99.599% |
| Universe Pharmaceuticals INC | 5.48 Million USD | 73.296% |
| DURECT Corporation | 20.74 Million USD | 92.943% |
| ProPhase Labs, Inc. | 21.38 Million USD | 93.152% |
| Safety Shot Inc | 1.54 Million USD | 5.485% |
| Phibro Animal Health Corporation | 525.45 Million USD | 99.721% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | 44.701% |
| Alvotech | 1.07 Billion USD | 99.864% |
| Assertio Holdings, Inc. | 40.91 Million USD | 96.422% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 96.475% |
| Rockwell Medical, Inc. | 13.43 Million USD | 89.106% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -122.594% |
| Procaps Group S.A. | 285.93 Million USD | 99.488% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 91.357% |
| SCYNEXIS, Inc. | 15.08 Million USD | 90.292% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 90.323% |
| Viatris Inc. | 18.12 Billion USD | 99.992% |
| OptiNose, Inc. | 131.74 Million USD | 98.889% |
| Tilray Brands, Inc. | 387.31 Million USD | 99.622% |
| PetIQ, Inc. | 468.3 Million USD | 99.687% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -122.594% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 99.658% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 67.39 Million USD | 97.828% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 99.783% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -34.598% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 98.773% |
| Journey Medical Corporation | 17.73 Million USD | 91.743% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | 82.311% |
| Alpha Teknova, Inc. | 30.45 Million USD | 95.193% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | 29.851% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 98.877% |
| PainReform Ltd. | 86 Thousand USD | -1602.336% |
| Cosmos Health Inc. | 12.42 Million USD | 88.216% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 95.863% |
| TherapeuticsMD, Inc. | 8 Million USD | 81.711% |
| Embecta Corp. | 1.63 Billion USD | 99.911% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -2347.889% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 99.75% |
| Incannex Healthcare Limited | 373 Thousand USD | -292.496% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -41.708% |
| Shineco, Inc. | 29.65 Million USD | 95.063% |
| Procaps Group, S.A. | 285.93 Million USD | 99.488% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 99.536% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 98.519% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 99.763% |
| Alvotech | 1.07 Billion USD | 99.864% |
| Hempacco Co., Inc. | 13.72 Million USD | 89.333% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 97.656% |
| Bright Green Corporation | 1.85 Million USD | 20.941% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 99.729% |
| Kamada Ltd. | 8.74 Million USD | 83.267% |
| Indivior PLC | 281.6 Million USD | 99.48% |
| Evoke Pharma, Inc. | 5 Million USD | 70.72% |
| Flora Growth Corp. | 3.67 Million USD | 60.13% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -41.708% |
| Evolus, Inc. | 126.54 Million USD | 98.843% |
| HUTCHMED (China) Limited | 86.13 Million USD | 98.3% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 99.765% |
| Akanda Corp. | 3.99 Million USD | 63.389% |